Press Release: Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025

Dow Jones

01-23

Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025

SKILLMAN, N.J.--(BUSINESS WIRE)--January 23, 2025--

Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025.

The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a replay made available after the live event.

About Kenvue

Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno$(R)$ , BAND-AID(R) Brand, Johnson's(R) , Listerine(R) , Neutrogena(R) and Tylenol(R) , are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250123211823/en/

 
    CONTACT:    Investor Relations:

Sofya Tsinis

Kenvue_IR@Kenvue.com

Media Relations:

Melissa Witt

Media@Kenvue.com

(END) Dow Jones Newswires

January 23, 2025 06:47 ET (11:47 GMT)

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2505099078"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2505099078\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2505099078?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-23 19:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2505099078","market":"hk","top_or_hot":-1,"title":"Press Release: Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 \n</p>\n<pre>\nSKILLMAN, N.J.--(BUSINESS WIRE)--January 23, 2025-- \n</pre>\n<p>\n     <a href=\"https://laohu8.com/S/KVUE\">Kenvue Inc</a>. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. \n</p>\n<p>\n     The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a replay made available after the live event. \n</p>\n<p>\n     About Kenvue \n</p>\n<p>\n     Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno<a href=\"https://laohu8.com/S/R\">$(R)$</a> , BAND-AID(R) Brand, Johnson's(R) , Listerine(R) , Neutrogena(R) and Tylenol(R) , are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com. \n</p>\n<p>\n     View source version on businesswire.com: https://www.businesswire.com/news/home/20250123211823/en/ \n</p>\n<pre>\n \n    CONTACT:    Investor Relations: \n</pre>\n<p>\n     Sofya Tsinis \n</p>\n<p>\n     Kenvue_IR@Kenvue.com \n</p>\n<p>\n     Media Relations: \n</p>\n<p>\n     Melissa Witt \n</p>\n<p>\n     Media@Kenvue.com \n</p>\n<pre>\n \n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 23, 2025 06:47 ET (11:47 GMT)\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Press Release: Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPress Release: Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-23 19:47</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 \n</p>\n<pre>\nSKILLMAN, N.J.--(BUSINESS WIRE)--January 23, 2025-- \n</pre>\n<p>\n     <a href=\"https://laohu8.com/S/KVUE\">Kenvue Inc</a>. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. \n</p>\n<p>\n     The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a replay made available after the live event. \n</p>\n<p>\n     About Kenvue \n</p>\n<p>\n     Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno<a href=\"https://laohu8.com/S/R\">$(R)$</a> , BAND-AID(R) Brand, Johnson's(R) , Listerine(R) , Neutrogena(R) and Tylenol(R) , are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com. \n</p>\n<p>\n     View source version on businesswire.com: https://www.businesswire.com/news/home/20250123211823/en/ \n</p>\n<pre>\n \n    CONTACT:    Investor Relations: \n</pre>\n<p>\n     Sofya Tsinis \n</p>\n<p>\n     Kenvue_IR@Kenvue.com \n</p>\n<p>\n     Media Relations: \n</p>\n<p>\n     Melissa Witt \n</p>\n<p>\n     Media@Kenvue.com \n</p>\n<pre>\n \n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 23, 2025 06:47 ET (11:47 GMT)\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B3T34201.USD","symbol_name":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2505099078","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2505099078","pubTimestamp":1737632820,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Kenvue Inc.  will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025.Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno , BAND-AID Brand, Johnson's , Listerine , Neutrogena and Tylenol , are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4588":"碎股","R":"瑞德系统","BK4232":"货物陆运","BK4183":"个人用品","BK4022":"陆运","KVUE":"Kenvue Inc","BK4585":"ETF&股票定投概念"},"translate_title":"新闻稿：Kenvue将于2025年2月6日公布2024年第四季度和全年业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KVUE":0.9,"R":1},"content_text":"Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 \n\n\nSKILLMAN, N.J.--(BUSINESS WIRE)--January 23, 2025-- \n\n\nKenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. \n\n\n     The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a replay made available after the live event. \n\n\n     About Kenvue \n\n\n     Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno$(R)$ , BAND-AID(R) Brand, Johnson's(R) , Listerine(R) , Neutrogena(R) and Tylenol(R) , are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com. \n\n\n     View source version on businesswire.com: https://www.businesswire.com/news/home/20250123211823/en/ \n\n\n \n    CONTACT:    Investor Relations: \n\n\n     Sofya Tsinis \n\n\n     Kenvue_IR@Kenvue.com \n\n\n     Media Relations: \n\n\n     Melissa Witt \n\n\n     Media@Kenvue.com \n\n\n \n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 23, 2025 06:47 ET (11:47 GMT)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}